Huntsman Cancer Institute earned national recognition for excellence in cancer care, including a top 10 ranking by Money and top ratings from Newsweek and U.S. News & World Report.
Proposed $50 million, 5-year deal with HPE would enlarge the U's computing power 3.5-fold using NVIDIA chips, driving new discoveries and innovation in cancer care and beyond.
Bradley Cairns, PhD, takes the helm as CEO of Huntsman Cancer Institute, continuing the legacy of excellence in cancer research, care, and community impact.
Huntsman Cancer Institute has appointed experienced leaders to guide its growing research and clinical program in theranostics, a promising new way to find and treat cancer.
Summary can be up to 30 words (words not characters; 'a' and 'transdisciplinary' both count as one word). Keep it simple and save long titles for the post.
Summary can be up to 30 words (words not characters; 'a' and 'transdisciplinary' both count as one word). Keep it simple and save long titles for the post.
The Senator Orrin G. Hatch Proton Therapy Center, the first and only in the region, is expanding. The project will double patient capacity and enhance access to innovative radiation treatment.
Huntsman Cancer Institute, alongside the Price College of Engineering and other departments at the ÑÇÖÞ×ÔοÊÓƵ of Utah, awarded grants to interdisciplinary research teams seeking innovative engineering solutions for cancer challenges.
After 20 years of transformative leadership, Mary Beckerle steps down as CEO and Brad Cairns is named successor to continue advancing cancer research and care across the Mountain West.
Three new physician-scientists have been welcomed to The Society of Huntsman Translational Scholars, recognizing their groundbreaking work in translating cancer research into real-world innovations that improve patient care.
Two Huntsman Cancer Institute researchers are recognized with endowed chairs. Endowed chairs are created through philanthropy and honor accomplishments in research.
Sigma Chi International Fraternity announces $31 million pledge to create the Sigma Chi Center for Advanced Therapeutics and Innovation at Huntsman Cancer Institute, the largest pledge in the fraternity’s history.
New drug therapy gives hope to advanced melanoma patients, personalized exercise plans enhance lung cancer patient recovery, and patient receives first allogeneic stem cell transplant from a deceased organ donor.
A nationally recognized cancer surgeon and academic leader, Gamblin brings deep expertise in cancer care, research, and innovation to advance surgical oncology across the Mountain West.
With a focus on innovation and collaboration, Welm will lead efforts to advance the Department of Oncological Sciences’ academic mission and scientific excellence, while positioning the department for national distinction.
